• The Journal of the Korea Contents Association
• /
• v.10 no.4
• /
• pp.257-264
• /
• 2010

Though existent a transcranial magnetic stimulation makes various treatment and diagnostic sine waveform of fixed stimulation pulse, there is limitation. In this research, because strength, pulse width, pulse pattern required in treatment and diagnostic introduce other Cockroft-Walton circuit and half bridge inverter frequency and voltage variable become new device propose wish to. Have more advantages than existing device. First, do not have high voltage transformer. Second, switching loss can be less, and control output energy precisely. Three, stimulation strengths, pulse width, pulse pattern are various. As a result, sought special quality and an experiment that is improved applying inverter and cockroft - Walton circuit is half bridge inverter that do not use transformer.

• Journal of the Korea Institute of Information and Communication Engineering
• /
• v.14 no.3
• /
• pp.729-736
• /
• 2010

In this study, a magnetic stimulation (MS) device with controllable pulse forming technology and pulse shape (MS) is described. The MS device uses an IGBT with appropriate snubbers to switch coil currents up to 6 kA, enabling pulse forming technology control from 5 s to over 100 s. The induced electric field pulses use 2% - 34% less energy and generate 57% - 67% less coil heating compared to matched conventional cosine pulses. MS is used to stimulate rhesus monkey motor cortex in vivo with pulse forming technology of 20 to 100 s, demonstrating the expected decrease of threshold pulse amplitude with increasing pulse forming technology. The technological solutions used in the MS prototype can expand functionality, and reduce power consumption and coil heating in MS, enhancing its research and therapeutic applications.

• The Journal of the Korea Contents Association
• /
• v.9 no.11
• /
• pp.289-296
• /
• 2009

In this study, I presented power control unit with potential use in the magnetic stimulation of biological systems. The effect of the magnetic stimulation depends on the geometry and orientation of the induced electric field as well as on the current pulse waveform delivered by the stimulator coil. TMS is achieved from the outside of the head using pulses of electromagnetic field that induce an electric field in the brain. There are numerous possibities in the applications TMS, such as diagnosis and therapy through the brain stimulation. These factors are very important to define the equipment requirements and characteristics in that the topology of the power supply and the size and geometry of the coil. The proposed solution is the generation of current pulses with variable amplitude and duration, according to a user defined input. Another solution is the topology that uses elements to store and transfer energy from the power source to the load. In addition to proposed topology, an adequate control strategy and right set of the power circuit parameters made possible to obtain unipolar waves and bipolar waves.

• Proceedings of the Korean Institute of Information and Commucation Sciences Conference
• /
• 2009.10a
• /
• pp.325-328
• /
• 2009

In this study, A Magnetic stimulation Pulse Train control technique is introduced and applied to Flyback converter operating in discontinuous conduction mode. In contrast to the conventional pulse width modulation control scheme, the principal idea of a Magnetic stimulation Pulse Train is to achieve output voltage regulation using high and low power pulses. The proposed technique is applicable to any converter operating in discontinuous conduction. However, this work mainly focuses on Flyback topology. In this paper, the main mathematical concept of the new control algorithm is introduced and simulations as well as experimental results are presented.

• Journal of Yeungnam Medical Science
• /
• v.22 no.1
• /
• pp.96-103
• /
• 2005

The motor recovery mechanism of a 21-year-old male monoparetic patient with cerebral palsy, who had complained of a mild weakness on his right hand since infancy, was examined using functional Magnetic Resonance Imaging (fMRI) and Transcranial Magnetic Stimulation (TMS). The patient showed mild motor impairment on the right hand. MRI located the main lesion on the left precentral knob of the brain. fMRI was performed on this patient as well as 8 control subjects using the Blood Oxygen Level Dependent technique at 1.5 T with a standard head coil. The motor activation task consisted of finger flexionextension exercises at 1 Hz cycles. TMS was carried out using a round coil. The anterior portion of the coil was applied tangentially to the scalp at a 1.0 cm separation. Magnetic stimulation was carried out with the maximal output. The Motor Evoked Potentials (MEPs) from both Abductor Pollicis Brevis muscles (APB) were obtained simultaneously. fMRI revealed that the unaffected (right) primary sensori-motor cortex (SM1), which was centered on precentral knob, was activated by the hand movements of the control subjects as well as by the unaffected (left) hand movements of the patient. However, the affected(right) hand movements of the patient activated the medial portion of the injured precentral knob of the left SM1. The optimal scalp site for the affected (right) APB was located at 1 cm medial to that of the unaffected (left) APB. When the optimal scalp site was stimulated, the MEP characteristics from the affected (right) APB showed a delayed latency, lower amplitude, and a distorted figure compared with that of the unaffected (left) APB. Therefore, the motor function of the affected (right) hand was shown to be reorganized in the medial portion of the injured precentral knob.

• The Korean Society of Law and Medicine
• /
• v.21 no.2
• /
• pp.209-244
• /
• 2020

TMS and tDCS are non-invasive devices that treat the diseases of patients or individual users, and manage or improve their health by applying stimulation to a brain through magnetism and electricity. The effect and safety of these devices have proved to be valid in several diseases, but research in this area is still much going on. Despite increasing cases of their application, legislations directly regulating TMS and tDCS are hard to find. Legal regulation regarding TMS and tDCS in the United States, Germany and Japan reveals that while TMS has been approved as a medical device with a moderate risk, tDCS has not yet earned approval as a medical device. However, the recent FDA guidance, European MDR changes, recalls in the US, and relevant legal provisions of Germany and Japan, as well as recommendations from expert groups all show signs of tDCS growing closer to getting approved as a medical device. Of course, safety and efficacy of tDCS can still be regulated as a general product instead of as a medical device. Considering multiple potential impacts on a human brain, however, the need for independent regulation is urgent. South Korea also lacks legal provisions explicitly regulating TMS and tDCS, but they fall into the category of the grade 3 medical devices according to the notifications of the Korean Ministry of Food and Drug Safety. And safety and efficacy of TMS are to be evaluated in compliance with the US FDA guidance. But no specific guidelines exist for tDCS yet. Given that tDCS devices are used in some hospitals in reality, and also at home by individual buyers, such a regulatory gap must quickly be addressed. In a longer term, legal system needs to be in place capable of independently regulating non-invasive brain stimulating devices.